Cancer-Focused Biotech Lands $79.5M Series B Round
By Darcy Reddan · August 21, 2019, 2:58 PM EDT
Oncorus, a biotechnology company focused on cancer treatments, on Wednesday said it landed $79.5 million in its latest funding round, which will be used to advance its lead drug candidate to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login